10.46
Precedente Chiudi:
$10.82
Aprire:
$10.805
Volume 24 ore:
1,519
Relative Volume:
0.00
Capitalizzazione di mercato:
$5.99M
Reddito:
-
Utile/perdita netta:
$-15.42M
Rapporto P/E:
-5.6848
EPS:
-1.84
Flusso di cassa netto:
$-13.41M
1 W Prestazione:
-11.73%
1M Prestazione:
+1,992%
6M Prestazione:
+1,025%
1 anno Prestazione:
+393.40%
Indaptus Therapeutics Inc Stock (INDP) Company Profile
Nome
Indaptus Therapeutics Inc
Settore
Industria
Telefono
(646) 427-2727
Indirizzo
3 COLUMBUS CIRCLE, NEW YORK
Confronta INDP con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
INDP
Indaptus Therapeutics Inc
|
10.46 | 6.20M | 0 | -15.42M | -13.41M | -1.84 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Indaptus Therapeutics Inc Borsa (INDP) Ultime notizie
Indaptus Therapeutics Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - jammulinksnews.com
Is Indaptus Therapeutics Inc. a good long term investmentSkyrocketing returns - Autocar Professional
What drives Indaptus Therapeutics Inc. stock priceAccelerated profit realization - jammulinksnews.com
What analysts say about Indaptus Therapeutics Inc. stockUnstoppable profit momentum - jammulinksnews.com
Is Indaptus Therapeutics Inc. stock a good hedge against inflationFree Access to Community - Newser
How high can Indaptus Therapeutics Inc. stock price go in 2025Free Access to Community with 300% Return - Newser
what makes indaptus therapeutics inc. stock price move sharplyFree Step-by-Step Investment Guide - Newser
Indaptus Therapeutics regains compliance with Nasdaq minimum bid price rule - Investing.com Nigeria
Indaptus Regains Nasdaq Compliance with Bid Price - TipRanks
Indaptus Therapeutics (NASDAQ:INDP) Shares Down 3.1% – Should You Sell? - Defense World
What makes Indaptus Therapeutics Inc. stock price move sharplyFree Stock Market Query - Newser
How Indaptus Therapeutics Inc. stock performs during market volatilityFree Capital Allocation Plans - Newser
Why Indaptus Therapeutics Inc. stock attracts strong analyst attentionConsistent Growth Alert - Newser
Indaptus Therapeutics announces additional sale of $3.4M in private placement - TipRanks
Indaptus Therapeutics raises $5.7 million through convertible notes - Investing.com
Indaptus Therapeutics raises $5.7 million through convertible notes By Investing.com - Investing.com South Africa
Indaptus Therapeutics Raises $5.7 Million Through Convertible Promissory Notes and Warrants - Nasdaq
Indaptus Raises $5.7M in Private Placement: New Funding Accelerates Cancer Treatment Clinical Trials - Stock Titan
Indaptus Therapeutics Raises $5.7M for R&D Initiatives - TipRanks
Indaptus Therapeutics (INDP) Resumes Trading | INDP Stock News - GuruFocus
Indaptus Therapeutics (INDP) Trading Temporarily Suspended Ahead of Announcement | INDP Stock News - GuruFocus
Indaptus Therapeutics Announces Reverse Stock Split - citybiz
Why Did Indaptus Therapeutics Plunge 28.89%? - AInvest
3 Penny Stocks to Watch Now, 6/24/25 - TipRanks
Dow Jumps Over 200 Points; FactSet Research Shares Gain After Q3 Results - Benzinga
Indaptus Therapeutics (INDP) Secures $2.3M Through Convertible N - GuruFocus
Indaptus Therapeutics raises $2.3 million through convertible notes By Investing.com - Investing.com South Africa
Indaptus Therapeutics Announces Sale Of $2.3 Million In Private Placement Of Convertible Notes And Warrants - MarketScreener
Indaptus Therapeutics Completes $2.3M Private Placement - TipRanks
Indaptus Therapeutics Inc Azioni (INDP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):